Clinical Trial Update: Feasibility Study of Metformin Therapy in ADPKD [Phase 2]

View source ↗

Summary

Phase 2 feasibility study of metformin therapy in autosomal dominant polycystic kidney disease (ADPKD) completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Kidney Disease Autosomal Dominant

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Polycystic Kidney, Autosomal Dominant | Phase 2 | Status: COMPLETED | Results posted: 2021-09-05